Interleukin (IL)-33 is an important member of the IL-1 family that has pleiotropic activities in innate and adaptive immune responses in host defense and disease. It signals through its ligand-binding primary receptor ST2 and IL-1 receptor accessory protein (IL-1RAcP), both of which are members of the IL-1 receptor family. To clarify the interaction of IL-33 with its receptors, we determined the crystal structure of IL-33 in complex with the ectodomain of ST2 at a resolution of 3.27 Å. Coupled with structure-based mutagenesis and binding assay, the structural results define the molecular mechanism by which ST2 specifically recognizes IL-33. Structural comparison with other ligand-receptor complexes in the IL-1 family indicates that surface-charge complementarity is critical in determining ligand-binding specificity of IL-1 primary receptors. Combined crystallography and small-angle X-ray-scattering studies reveal that ST2 possesses hinge flexibility between the D3 domain and D1D2 module, whereas IL-1RAcP exhibits a rigid conformation in the unbound state in solution. The molecular flexibility of ST2 provides structural insights into domain-level conformational change of IL-1 primary receptors upon ligand binding, and the rigidity of IL-1RAcP explains its inability to bind ligands directly. The solution architecture of IL-33-ST2-IL-1RAcP complex from smallangle X-ray-scattering analysis resembles IL-1β-IL-1RII-IL-1RAcP and IL-1β-IL-1RI-IL-1RAcP crystal structures. The collective results confer IL-33 structure-function relationships, supporting and extending a general model for ligand-receptor assembly and activation in the IL-1 family.
protein-protein interaction | X-ray crystallography | SAXS | cytokine signaling I nterleukin (IL)-33 has important roles in initiating a type 2 immune response during infectious, inflammatory, and allergic diseases (1) (2) (3) (4) (5) . It was initially identified as a nuclear factor in endothelial cells and named NF-HEV (nuclear factor from high endothelial venules) (6, 7) . In 2005, it was rediscovered as a new member of the IL-1 family and an extracellular ligand for the orphan IL-1 receptor family member ST2 (8) . As an extracellular cytokine, IL-33 is involved in the polarization of Th2 cells and activation of mast cells, basophils, eosinophils, and natural killer cells (1) (2) (3) . Recent studies also discovered that the type 2 innate lymphoid cells (ILC2s) are major target cells of IL-33 (9, 10 ). ILC2s express a high level of ST2 and secrete large amounts of Th2 cytokines, most notably IL-5 and IL-13, when stimulated with IL-33 (11) (12) (13) . Activation of ILC2s is essential in the initiation of the type 2 immune response against helminth infection and during allergic diseases such as asthma (9, 10) .
IL-33 does not have a signal peptide and is synthesized with an N-terminal propeptide upstream of the IL-1-like cytokine domain. It is preferentially and constitutively expressed in the nuclei of structural and lining cells, particularly in epithelial and endothelial cells (14, 15) . Tissue damage caused by pathogen invasion or allergen exposure may lead to the release of IL-33 into extracellular environment from necrotic cells, which functions as an endogenous danger signal or alarmin (14, 16) . Full-length human IL-33 consists of 270 residues and is biologically active (17, 18) . It is also a substrate of serine proteases released by inflammatory cells recruited to the site of injury (18, 19) . The proteases elastase, cathespin G, and proteinase 3 cleave fulllength IL-33 to release N-terminal-truncated mature forms containing the IL-1-like cytokine domain: IL-33 , L-33 , and IL-33 (18) . These mature IL-33 forms process a 10-fold greater potency to activate ST2 than full-length IL-33 (18) . Caspase-1 was also suggested to cleave IL-33 to generate an active IL-33 that is the commercially available mature IL-33 form (8). However, it was later demonstrated that this cleavage site does not exist and cleavage by caspases at other sites actually inactivates IL-33 (17, 20, 21) .
The signaling of IL-33 depends on its binding to the primary receptor ST2 and subsequent recruitment of accessory receptor IL-1RAcP (8, 22, 23) . The ligand-binding-induced receptor heterodimerization results in the juxtaposition of the intracellular toll/interleukin-1 receptor (TIR) domains of both receptors, which is necessary and sufficient to activate NF-κB and MAPK pathways in the target cells (24) . Previously, we determined the complex structure of IL-1β with its decoy receptor Significance Interleukin (IL)-33 exerts its biological effects by binding to its specific primary receptor ST2 and the coreceptor IL-1 receptor accessory protein (IL-1RAcP). Through determining the crystal structure of IL-33 with ST2, we define the molecular basis for their specific recognition and propose that surface-charge complementarity is critical in determining ligand-binding specificity of IL-1 primary receptors. Small-angle X-ray-scattering studies also reveal that ST2 possesses significant interdomain flexibility, which is not present in the coreceptor IL-1RAcP. These molecular features are consistent with their respective roles in ligand binding and signal transduction on cell surface. Small-angle X-ray-scattering results also support and extend a detailed stepwise model for ligand-receptor assembly and activation in the IL-1 family.
IL-1RII and accessory receptor IL-1RAcP (25) . Based on this structure and other previous studies, we proposed a general structural model for the assembly and activation of IL-1 family of cytokines with their receptors (25) . In this model, ligand recognition relies on interaction of IL-1 cytokine with its primary receptor: IL-1α and IL-1β with IL-1RI; IL-33 with ST2; IL-18 with  IL-18Rα; and IL-36α, IL-36β, and IL-36γ with IL-1Rrp2 (26) (27) (28) . The binding forms a composite surface to recruit accessory receptor IL-1RAcP shared by IL-1α, IL-1β, IL-33, IL-36α, IL-36β, and IL-36γ and IL-18Rβ by IL-18 (26, 27) . This general structural model is further supported by the subsequent structural determination of IL-1β with IL-1RI and IL-1RAcP (29) . However, there are still many key missing parts in the general structural model of ligand-receptor interaction in the IL-1 family. For example, the structural basis for specific recognition of IL-33 by ST2 and IL-18 by IL-18Rα, and promiscuous recognition of IL-36α, IL-36β, and IL-36γ by IL-1Rrp2 remains elusive. The proposed general model also needs further confirmation from structural studies of other signaling complexes in the IL-1 family. To address these issues, we studied the interaction of IL-33 with its receptors by a combination of X-ray crystallography and small-angle X-ray-scattering (SAXS) methods.
Results
Overall Structure. The complex structure of active IL-33 112-270 (Ser112 to Thr270) with ST2 ectodomain (Lys19 to Lys321) was determined at a resolution of 3.27 Å by the molecular replacement method (Table S1 and Fig. 1 ). The final model includes IL-33 residues Ser117 to Asn171, Gly179 to Val252, and Glu261 to Ser268 and ST2 residues Ser21 to Ser51, Ser56 to Lys223, Asn232 to Gly271, and Gly279 to Arg317. Three N-acetyl-Dglucosamine (NAG) glycans are linked to Asn95, Asn140, and Asn191 of ST2, respectively (Fig. 1) . Other missing residues were not built because of weak electron densities. The ectodomain of ST2 consists of three IgG-like domains (D1 to D3) as expected (Fig. 1) . The D1 and D2 domains pack together to form a single D1D2 module, to which the D3 domain is connected through a long linker (Fig. 1) . In the complex, the ST2 wraps around IL-33 like a grasping hand with all three domains (Fig. 1) .
IL-33 adopts a 12-stranded β-trefoil fold (Fig. S1 ). The crystal structure of IL-33 in the complex superimposes well with solution structure of IL-33 determined by NMR method with an r.m. s.d. of 1.2 Å for 123 matched Cα atoms (30) . Twelve β-strands forming the β-trefoil fold are conserved in both structures, whereas conformational variations reside in the loops connecting the strands, especially in loops β2-β3, β3-β4, β4-β5, β10-β11, and β11-β12 involved in receptor interaction (Fig. S1 ). The β4-β5 and β11-β12 loops are disordered in the crystal structure, and in the NMR structure, the β4-β5 loop is also the region with the most diverse conformation (Fig. S1 ). These two loops are involved in the recruitment of accessory receptor IL-1RAcP after the binding of IL-33 with ST2, and their roles are discussed below.
All members except SIGIRR in the IL-1 receptor family have three Ig-like domains (D1 to D3) in the extracellular region (26) . The packing and orientation between D1 and D2 domains in the D1D2 module are conserved among primary receptors ST2, IL-1RI, and IL-1RII, the structures of which have been determined (Fig. S2) (25, 29, 31, 32) . The linker connecting the D3 domain to the D1D2 module is flexible, resulting in different orientations of the D3 domain among these three primary receptors when they bind their respective ligands (Fig. S2 ). 2) . At site 1, thirteen IL-33 residues, from β3-strand, β1-β2, β2-β3, β3-β4, and β10-β11 loops, have contacts with the D1D2 module of ST2 receptor (Fig. S3 ). Among these residues, Glu144, Glu148, Asp149, and Asp244 form salt-bridge interactions with ST2 residues Arg38, Lys22, Arg198, and Arg35, respectively ( Fig. 2 ). Glu144 and Asp149 also form hydrogenbonding interactions with ST2 receptor main-chain atoms ( Fig.  2) . At site 2, eight IL-33 residues from β1-, β4-, β5-strands and β8-β9 loop have contacts with the D3 domain of ST2 (Fig. S3 ). The chemical nature here is a mixture of hydrophobic and hydrophilic interactions. Among the IL-33-interacting residues, four of them are hydrophobic and a significant hydrophobic cluster is formed by IL-33 residues Tyr164 and Leu182 and ST2 residues Leu246, Leu306, and Leu311 (Fig. 2) . Acidic residue Glu165 has salt-bridge interaction with Arg313 of ST2 (Fig. 2) .
Previous efforts to identify "hot spot" residues of IL-33 for ST2 interaction were based on NMR chemical-shift perturbation data and subsequent mutagenesis and affinity measurements (30) . Twenty-eight IL-33 mutants were examined, and only one mutant (E144K) had a pronounced effect on the interaction between IL-33 and ST2 by decreasing the affinity sevenfold from 0.45 to 3.15 nM (30) . We measured the ST2-binding affinities of IL-33 mutants identified by structural analysis of the IL-33/ST2 interface with surface plasmon resonance (SPR) method (Table  S2 ). These mutation sites were not examined in the previous report except the Glu144 position. In our measurements, wildtype IL-33 bound to ST2 ectodomain with an affinity of 0.74 nM (Table S2 and Fig. S4 ), comparable to the previously reported 0.45 nM (30) . All IL-33 mutations of acidic residues at site I (E144K, E148K, D149K, and D244K) decreased the ST2-binding affinity. E144K and D244K mutants exhibited ∼two-to threefold reduction from 0.74 to 1.89 and 1.65 nM, respectively (Table S2 and Fig. S4 ). Mutation E148K had a more pronounced effect on the binding with ∼sevenfold affinity reduction from 0.74 to 5.15 nM (Table S2 and Fig. S4 ). Mutation at Asp149 position (D149K) reduced the binding of IL-33 with ST2 to an undetectable level by SPR method (Table  S2 and Fig. S4 ). At site 2, mutation of acidic residue Glu165 (E165K) also decreased the binding affinity ∼eightfold from 0.74 to 6.07 nM, whereas mutations of hydrophobic residues Tyr163 and Leu182 had less effect on the binding (Table S2 and Fig. S4 ). IL-33-ST2 with them revealed a similar architecture with the involvement of all three Ig-like domains (D1 to D3) and two separate sites in ligand binding (Fig. 3A) . Site 1 is more structurally conserved than site 2 in different ligand-receptor pairs because of rigidity of the D1D2 module in different receptors. However, a more close examination revealed differences of IL-33 from IL-1β and IL-1Ra in receptor binding at site 1. We have shown that IL-33 acidic residues Glu144, Glu148, Asp149, and Asp244 form salt-bridge interactions with side chains of basic residues of ST2 receptor (Fig. 2) , which is also evidenced by the complementary electrostatic potential on the surfaces of IL-33 and ST2 at site 1 (Fig. 3B) . The surface of IL-33 at site 1 exhibits strong negative charge, and the corresponding surface of ST2 is dominated by positive charge (Fig. 3B) . In contrast, IL-1β-critical residues Arg21, Gln15, and Gln32 at site 1 interact with IL-1RI and IL-1RII mainly through van der Waals contacts and hydrogen bonds with receptor main-chain atoms (25, 29, 31) . This phenomenon has also been observed at the binding site 1 between IL-1Ra and IL-1RI (32) . Surface electrostatic-potential analyses also showed that the surfaces of IL-1β and IL-1Ra at site 1 are not dominated by negative charge, and the corresponding surfaces of IL-1RI and IL-1RII have no remarkable electrostatic properties (Fig. 3C) . Although the crystal structure of IL-18 in complex with IL-18Rα is not available, IL-18 has an obvious patch with negative charge at potential binding site 1 (Fig. 3D) (33, 34) , similar to that of IL-33. . At site 1, IL-33 acidic residues Glu144, Glu148, Asp149, and Asp244 form salt-bridge interactions with ST2 basic residues Arg38, Lys22, Arg198, and Arg35, respectively. Glu144 and Asp149 of IL-33 also have hydrogen-bonding interactions with ST2 main chain atoms. At site 2, IL-33 acidic residue Glu165 has salt-bridge interaction with Arg313 of ST2. A significant hydrophobic cluster at site 2 involves residues Tyr163 and Leu182 of IL-33 and Leu246, Leu306, and Leu311 of ST2. domains. However, the degree of flexibility between domains of the receptors correlated with their dynamic nature relevant to molecular recognition has not been investigated. Using a combination of crystallography and SAXS (35), we characterized the functional conformations of the receptors in solution and revealed conformational changes upon complex formation with the ligand. ST2 and IL-1RAcP SAXS data were collected (Fig.  S5 ) and further analyzed to determine whether the receptors exist as well-defined conformations or as an assembly of different conformers in solution by using the program BILBOMD (36) , in which the D1D2 module and D3 domain were treated as two separate rigid bodies connected by a flexible linker. In BIL-BOMD, 10,000 distinct conformers were generated by constrained molecular dynamics (MD) simulation, theoretical scattering profiles were calculated by FoXS (37) , and then Minimal Ensemble Search (MES) were applied to select a subset containing one to four conformers that best fit the experimental data (36) . The full-atomic model is crucial to match the experimental data (38) ; therefore, missing loops and residues in ST2 and IL-1RAcP ligand-bound crystal structures were constructed with MODELLER (39) . For ST2, the theoretically calculated SAXS profile from initial model does not agree well with experimental data (χ = 5.0) (Fig. 4A ). An ensemble of three conformers fits the data significantly much better (χ = 1.7) than the single best-fit conformer (χ = 3.2) (Fig. 4A) . For IL-1RAcP, the single best-fit model with a small movement in D3 domain compared with crystal structure improves the fit (χ = 1.1) than the initial full-atomic model derived from crystal structure (χ = 3.9), and MES approach does not improve the fit (χ = 1.1) (Fig. 4B) .
The crystal structure of IL-33-ST2-IL-1RAcP complex is still not available. To resolve its molecular architecture, we generated a model of IL-33-ST2-IL-1RAcP by fitting IL-33-ST2 crystal structure into the previously determined IL-1β-IL-1RII-IL-1RAcP ternary complex and replacing IL-1β and IL-1RII with IL-33 and ST2, respectively. To validate this model and to compare the receptors in ligand-bound and ligand-unbound state, we collected the SAXS data on IL-33-ST2 and IL-33-ST2-IL1RAcP complexes (Fig. S5) . Theoretical SAXS profiles from initial full-atomic models of IL-33-ST2 and IL-33-ST2-IL1RAcP complexes fit the experimental data well, with the χ value of 1.5 and 1.8, respectively (Fig. 5 A and B) . 
Discussion
The IL-1 family consists of eleven members, so it is important to examine conserved and variable structural features relevant to a general understanding of their interactions with receptors and activities. In the present study, we determined the crystal structure of IL-33 in complex with the ectodomain of its primary receptor ST2 (Fig. 1 and Table S1 ) and delineated the solution conformational states of ST2 and accessory receptor IL-1RAcP (Fig. 4) , which illuminate the structural basis of how the specific IL-33-receptor complex drives biological processes and how the level of flexibility within receptors is relevant to molecular recognition. Structural comparison with IL-1β-IL-1RI, IL-1β-IL-1RII, and IL-1Ra-IL-1RI pairs showed that all ligand-binding IL-1 primary receptors recognize their respective ligands in a similar way (Fig. 3A) (25, 29, 31, 32) . However, ST2-receptor specifically recognizes IL-33, whereas IL-1RI and IL-1RII promiscuously recognize IL-1α, IL-1β, and IL-1Ra, which share a similar β-trefoil fold but with low sequence homologies. Our structure-based mutagenesis and binding assay identified IL-33 acidic residues Glu148 and Asp149 at site 1 and Glu165 at site 2, important for high-affinity binding with ST2 receptor (Fig. 2 and Table S2 ), and these residues form specific salt-bridge interactions with basic residues of ST2 receptor. Surface electrostaticpotential analysis also revealed obvious charge complementarity at site 1 of the IL-33/ST2 binding interface (Fig. 3B) . In contrast, there is no obvious charge complementarity at the binding interfaces of IL-1RI and IL-1RII in complex with IL-1β and IL1Ra (Fig. 3C) . IL-18 is another member in the IL-1 family that has its own specific primary receptor, IL-18Rα, and it has a negative charge patch at the surface of binding site 1 (Fig. 3D) . Therefore, we propose that charge complementarity may play important roles in the specific recognition of IL-18 by IL-18Rα. We further suggest that ST2 and IL-18Rα mainly use charge complementarity at site 1 to achieve ligand-binding specificity, whereas IL-1RI, IL-1RII, and IL-1Rrp2 avoid them to achieve ligand-binding promiscuity.
SAXS studies also revealed that ST2 has naturally built-in flexibility between the D3 domain and D1D2 module. MES-based search selected a subset of three major conformers of ST2 ectodomain, which can be regarded as open, half-open, and closed states considering the orientation of the D3 domain with respect to the D1D2 module (Fig. S6A) . The ST2 half-open conformer resembles the conformation of ST2 after binding to IL-33 (Fig. S6B) , and the ST2 closed conformer resembles the conformation of IL-1RI when it binds to a peptide antagonist (40) (Fig. S6B) . Although IL-1RI has not been structurally studied in solution, in the complex, IL-1RI is able to adopt at least two conformations: one is the closed state in complex with the peptide antagonist (40) , and the other is the half-open conformation in complex with its cytokine ligands IL-1β or IL-1Ra (31, 32) . Together, these results suggest that primary receptors in the IL-1 family are flexible between the D3 domain and D1D2 module, which enables the D3 domain to bind their respective ligands from the bottom side at site 2. After binding, the IL-33-ST2 complex forms a rigid conformation, evidenced by the excellent match of one single conformer with the experimental SAXS data (Fig. 5A ). This rigid binary complex then provides a molecular platform for the recruitment of accessory receptor IL-1RAcP.
Our SAXS studies revealed that IL-1RAcP has a preference for a single conformation in solution (Fig. 4B) , indicating that IL1RAcP is not as flexible as ST2 between the D3 domain and D1D2 module. IL-1RAcP conformer in solution is even more closed between the D3 domain and D1D2 module compared with its crystal structure in ligand-bound state (Fig. 4B) (25, 29) . The previously determined crystal structure has implied that IL1RAcP is rigid because the linker is not extended and has interactions with the D1D2 module and D3 domain (25) . However, that structure captures the state of IL-1RAcP in the ternary complex. Here, we have found a similarly rigid conformation of unbound IL-1RAcP in solution by SAXS study, and this supports our previous hypothesis that steric hindrance contributes to the inability of IL-1RAcP to directly engage cytokines.
A prior SAXS study proposed an IL-33-ST2-IL-1RAcP model that is different from the determined IL-1β-IL-1RII-IL-1RAcP and IL-1β-IL-1RI-IL-1RAcP crystal structures (30) . With determined IL-33-ST2 and IL-1RAcP crystal structures, we are able to interpret SAXS data in a more accurate way (41) . The IL-33-ST2-IL-1RAcP ternary complex model derived from IL-1β-IL-1RII-IL-1RAcP structure fitted the experimental SAXS data well (Fig. 5B) , consistent with the "LEFT" architecture of the IL-1 signaling complex (25, 29) . In the IL-1β-IL-1RII-IL-1RAcP and IL-1β-IL-1RI-IL-1RAcP structures (25, 29) , IL-1β β4-β5 and β11-β12 loops are involved in the interaction with IL-1RAcP. These two loops are disordered in the IL-33-ST2 complex structure, and they are expected to adopt suitable conformations to contact with IL-1RAcP. IL-1RAcP is a shared cytokine receptor like common γ-chain and gp130 (42) , but the structural basis for its promiscuous binding by distinct ligand-primary receptor complexes is still not well understood. The β4-β5 and β11-β12 loops binding to IL-1RAcP have low sequence homology among different agonists (IL-1α, IL-1β, IL-33, IL-36α, IL-36β, and IL-36γ). The D2 and D3 domains also have low sequence homology among different primary receptors including IL-1RI, IL-1RII, ST2, and IL-1Rrp2. However, interactions shared by IL-1RI and IL-1RII to bind IL-1RAcP are found in a small hydrophobic patch, which is formed by Ile135, Leu180, and Ile181 in IL-1RAcP and Val160 (Val173 in IL-1RII) and Ile165 (Leu180 in IL-1RII) in IL-1RI (29) . ST2 has His162 and Val167 in these two positions, respectively, and there is another hydrophobic residue Phe165 nearby (Fig. S7) . Therefore, among many disparate molecular interactions, this conserved hydrophobic patch may play important roles in the binding of IL-1RAcP by different ligand-primary receptor complexes. The crossreactivity of IL-1RAcP would be better understood by future crystal structural studies of other signaling complexes involving IL-1RAcP in the IL-1 family.
Our results support a more detailed stepwise assembly and activation model of the IL-33 signaling complex (Fig. S8) . The ectodomain of ST2 adopts different conformation before IL-33 binding because of flexibility between the D3 domain and D1D2 module. The concave electropositive surface at binding site 1 specifically recognizes the electronegative surface of IL-33, initiating the specific recognition of IL-33. The D3 domain of ST2 adopts a final best position to cover the bound IL-33 from the bottom side at binding site 2, helping form a very stable IL-33-ST2 binary complex with a rigid conformation. The IL-33-ST2 complex then recruits accessory receptor IL-1RAcP, contributed to by both IL-33 and ST2. The final assembly of the ternary complex juxtaposes the intracellular TIR domains of ST2 and IL1RAcP receptors, which triggers the subsequent intracellular signaling pathways. This stepwise binding model and built-in flexibility of ligand-binding primary receptors may be general to other members of the IL-1 family.
Materials and Methods
Plasmid DNA constructions, protein expression and purification, crystallization and diffraction data collection, structural determination and refinement, and surface plasmon resonance analysis are described in detail in SI Materials and Methods. SAXS data were collected at the Advanced Light Source beamline 12.3.1 (structurally integrated biology for life sciences), Lawrence Berkeley National Laboratory as described (43, 44) . SAXS data analysis and modeling are described in SI Materials and Methods.
